Morning Market Losers By: Benzinga via Benzinga December 16, 2014 at 09:57 AM EST Cyclacel Pharmaceuticals (NASDAQ: CYCC) shares dipped 70.04% to $0.85 after the company announced enrollment of 486 patients, and ... Read More >> Related Stocks: Exact Sciences Cor Hydrogenics Corp Navistar International Corp Yandex Ord Shs Class A